Pharmaron Beijing Co., Ltd — Share Issue/Capital Change 2019

Nov 13, 2019

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

This Application Form uses the same terms as defined in the prospectus of Pharmaron Beijing Co., Ltd. (the “ Company ”) dated Thursday, November 14, 2019 (the “ Prospectus ”).

Staple your 本申請表格使用康龍化成（北京）新藥技術股份有限公司（「 本公司 」）於2019 年11 月14 日（星期四）刊發的招股說明書 payment （「 招股說明書 」）所界定的詞語。 here Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in 請將股款 the United States without registration or an exemption from registration under the U.S. Securities Act. 緊釘在此 本申請表格及招股說明書概不構成在香港以外司法管轄權區要約出售或游說要約購買香港發售股份。若無根據美國證 券法登記或豁免登記，香港發售股份不得在美國提呈發售或出售。 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 在任何根據當地法例不得發送、派發或複製本申請表格及招股說明書的司法管轄權區內概不得發送或派發或複製（不論 方式，也不論全部或部分）本申請表格及招股說明書。 Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection – Documents Delivered to the Registrar of Companies” section in Appendix VIII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股說明書、所有相關申請表格及招股說明書附錄八「送呈香港公司註冊處處長及備查文件－送呈公司註冊處處長文 件」一節所述其他文件已遵照第32章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香32章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香342C條的規定，送呈香港公司註冊處處長登記。香條的規定，送呈香港公司註冊處處長登記。香 港交易及結算所有限公司、香港聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公司（「 香港結算 」）、香港證券及 期貨事務監察委員會（「 證監會 」）及香港公司註冊處處長對此等文件的內容概不負責。 Pharmaron Beijing Co., Ltd.[*] 康龍化成（北京）新藥技術股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) （於中華人民共和國註冊成立的股份有限公司） Stock Code : 3759 股份代號 : 3759 Maximum Offer Price : HK$39.50 per H Share (payable in full on application in Hong Kong dollars, subject to refund on final pricing), plus brokerage of 1%, a SFC transaction levy of 0.0027% and a Hong Kong Stock Exchange trading fee of 0.005% 最高發售價 : 每股H股39.50港元（須於申請時以港元繳足， 最終定價後多繳款項可予退還），另加1% 經紀佣金、0.0027%證監會交易徵費及 0.005%香港聯交所交易費 You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ， 一 。 招股說明書尚有關於申請程序的其他資料 本申請表格應與招股說明書 併閱讀 Application Form 申請表格 To: Pharmaron Beijing Co., Ltd. 致： 康龍化成（北京）新藥技術股份有限公司 Joint Sponsors 聯席保薦人 Joint Global Coordinators 聯席全球協調人 Joint Bookrunners 聯席賬簿管理人 Hong Kong Underwriters 香港承銷商

Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection – Documents Delivered to the Registrar of Companies” section in Appendix VIII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股說明書、所有相關申請表格及招股說明書附錄八「送呈香港公司註冊處處長及備查文件－送呈公司註冊處處長文 件」一節所述其他文件已遵照第32章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香32章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香章公司（清盤及雜項條文）條例第342C條的規定，送呈香港公司註冊處處長登記。香342C條的規定，送呈香港公司註冊處處長登記。香條的規定，送呈香港公司註冊處處長登記。香 港交易及結算所有限公司、香港聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公司（「 香港結算 」）、香港證券及 期貨事務監察委員會（「 證監會 」）及香港公司註冊處處長對此等文件的內容概不負責。

• Applicants’ declaration

申請人聲明

本人 ~~╱~~ 吾等同意本申請表格及招股說明書的條款及條件 以及申請程序。請參閱本申請表格「填交本申請表格的效 用」一節。

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

警告：任何人士只限作出一次為其利益而進行的認購申 請。請參閱本申請表格「填交本申請表格的效用」一節最 後四點。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of “Effect of completing and submitting this Application Form” section.

• For identification purposes only 僅供識別。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): 由（所有）申請人簽署（所有聯名申請人必須簽署）：

For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀 由（所有）申請人簽署（所有聯名申請人必須簽署）： Broker No. 經紀號碼 Broker’s Chop 經紀印章 Date 日期： / / D日 M月 Y年 Number of Hong Kong Offer Shares applied for (not more than Cheque/banker’s cashier order number 支票 ╱ 銀行本票號碼 5,826,800 H Shares) 申請香港發售股份數目（不超過5,826,800股H股） Name of bank on which cheque/banker’s cashier order is drawn (see “How to make your application” section) 兌現支票 ╱ 銀行本 Total amount 總額 票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in BLOCK letters) 英文姓名╱名稱（正楷） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號碼╱護 照號碼╱香港商業登記號碼（請刪除不適用者） Names of all other joint applicants in English (if any, in BLOCK letters) Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. of all other joint applicants (Please delete as appropriate) 所有其他聯名申 所有其他聯名申請人的英文姓名╱名稱（如有，正楷） 請人的香港身份證號碼╱護照號碼╱香港商業登記號碼（請刪除不適用者） 1) 1) 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only in BLOCK letters) 香港地址（以英文正楷填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identification code for each (joint) beneficial owner. 由代名人遞交：代名人若不填寫本節，是 項認購申請將視作為 閣下利益提出。請填寫每名（聯名）實 益擁有人的賬戶號碼或識別編碼。 ADDRESS LABEL 地址標貼 (Your name(s) and address in Hong Kong in BLOCK letters 請用英文正楷填寫 姓名╱名稱 及香港 地址 )

For internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• *(1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity. 個別人士須填寫其香港身份證號碼或（如非香港身份證持有人）護照號碼。法人團體須填寫其香港 商業登記號碼。每名聯名申請人均須提供其相關號碼。該等香港身份證號碼╱護照號碼╱香港商 業登記號碼將轉交第三方以核實申請表格的有效性。

• (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the firstnamed applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 日後如需退回申請股款，退款支票上或會印有 閣下或（如屬聯名申請人）排名首位申請人的香港 身份證號碼╱護照號碼的一部分。銀行兌現退款支票前或會要求查證 閣下的香港身份證號碼╱ 護照號碼。

• (3) If an application is made by an unlisted company and: • the principal business of that company is dealing in securities; and • you exercise statutory control over that company, then the application will be treated as being made for your benefit. 倘若申請人是一家非上市公司，而： • 該公司主要從事證券買賣業務；及 • 閣下對該公司可行使法定控制權， 是項申請將視作為 閣下的利益提出。

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 100 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

			No. of Amount No. of Amount	No. of Amount No. of Amount
2. 3.		Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ Hong Kong Offer Shares applied for payable on application HK$ 100 200 300 400 500 600 700 800 900 1,000 1,500 2,000 3,989.81 7,979.61 11,969.41 15,959.22 19,949.02 23,938.83 27,928.63 31,918.43 35,908.24 39,898.05 59,847.06 79,796.08 2,500 3,000 3,500 4,000 4,500 5,000 6,000 7,000 8,000 9,000 10,000 20,000 99,745.11 119,694.13 139,643.14 159,592.17 179,541.19 199,490.21 239,388.25 279,286.30 319,184.33 359,082.38 398,980.42 797,960.83 30,000 40,000 50,000 60,000 70,000 80,000 90,000 100,000 200,000 300,000 400,000 500,000 1,196,941.25 1,595,921.66 1,994,902.08 2,393,882.49 2,792,862.91 3,191,843.32 3,590,823.74 3,989,804.15 7,979,608.30 11,969,412.45 15,959,216.60 19,949,020.75 600,000 700,000 800,000 900,000 1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 5,826,800(1) 23,938,824.90 27,928,629.05 31,918,433.20 35,908,237.35 39,898,041.50 79,796,083.00 119,694,124.50 159,592,166.00 199,490,207.50 232,477,908.21 (1)Maximum number of Hong Kong Offer Shares you may applyfor. Complete the form in English in BLOCK letters and sign it. Only written signatures will be accepted (and not by way of personal chop). Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements: The cheque must: Banker’s cashier order must: • be in Hong Kong dollars; • not be post-dated; • be made payable to “CMB WING LUNG (NOMINEES) LIMITED – PHARMARON PUBLIC OFFER”; Sample 樣版
		•	be crossed “Account Payee Only”;
		•	be drawn on your Hong Kong dollar bank	• be issued by a licensed bank in Hong
			account in Hong Kong; and	Kong, and have your name certified on the
		•	show your account name, which must	back by a person authorised by the bank.
			either be pre-printed on the cheque, or	The name on the banker’s cashier order
			be endorsed on the back by a person	must correspond with your name. If it is
			authorised by the bank. This account name	a joint application, the name on the back
			must correspond with your name. If it is a	of the banker’s cashier order must be the
			joint application, the account name must	same as the first-named applicant’s name.
			be the same as the first-named applicant’s
			name.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of:

CMB Wing Lung Bank Limited Branch Name Address Hong Kong Island Head Office 45 Des Voeux Road Central North Point Branch 361 King’s Road Central District Branch 189 Des Voeux Road Central Kowloon Mongkok Branch B/F CMB Wing Lung Bank Centre, 636 Nathan Road Tsim Sha Tsui Branch 4 Carnarvon Road 5. Your Application Form can be lodged at these times: – Thursday, November 14, 2019 9:00 a.m. to 5:00 p.m. – Friday, November 15, 2019 9:00 a.m. to 5:00 p.m. – Saturday, November 16, 2019 9:00 a.m. to 1:00 p.m. – Monday, November 18, 2019 9:00 a.m. to 5:00 p.m. – Tuesday, November 19, 2019 9:00 a.m. to 5:00 p.m. Wednesday, November 20, 2019 – 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Wednesday, November 20, 2019. The application lists will be opened between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in “10. Effect of Bad Weather on the Opening of the Application Lists” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus. The applications for the Hong Kong Offer Shares will commence on Thursday, November 14, 2019 through Wednesday, November 20, 2019. The application monies (including the brokerage fees, SFC transaction levies and Stock Exchange trading fees) will be held by the receiving bank and on behalf of the Company after the closing of the application lists and the refund monies, if any, will be returned to the applicants without interest on or before Wednesday, November 27, 2019. Investors should be aware that the dealings in the H Shares on the Stock Exchange are expected to commence on Thursday, November 28, 2019.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

申請手續

1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。

1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。	1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。	1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。	1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。	1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100股香港發售股份，並為下表 所列的其中一個數目，否則恕不受理。
可供申請認購股份數目及應繳款項
申請認購的 香港發售 股份數目 申請時 應繳款項 港元	申請認購的 香港發售 股份數目 申請時 應繳款項 港元	申請認購的 香港發售 股份數目 申請時 應繳款項 港元		申請認購的 香港發售 股份數目 申請時 應繳款項 港元
100 200 300 400 500 600 700 800 900 1,000 1,500 2,000 3,989.81 7,979.61 11,969.41 15,959.22 19,949.02 23,938.83 27,928.63 31,918.43 35,908.24 39,898.05 59,847.06 79,796.08	2,500 3,000 3,500 4,000 4,500 5,000 6,000 7,000 8,000 9,000 10,000 20,000 99,745.11 119,694.13 139,643.14 159,592.17 179,541.19 199,490.21 239,388.25 279,286.30 319,184.33 359,082.38 398,980.42 797,960.83	30,000 40,000 50,000 60,000 70,000 80,000 90,000 100,000 200,000 300,000 400,000 500,000 1,196,941.25 1,595,921.66 1,994,902.08 2,393,882.49 2,792,862.91 3,191,843.32 3,590,823.74 3,989,804.15 7,979,608.30 11,969,412.45 15,959,216.60 19,949,020.75 樣		600,000 700,000 800,000 900,000 1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 5,826,800(1) 23,938,824.90 27,928,629.05 31,918,433.20 35,908,237.35 39,898,041.50 79,796,083.00 119,694,124.50 159,592,166.00 199,490,207.50 232,477,908.21 (1) 閣下可申請認購的香港發售股 份最高數目。 版
2. 以英文正楷填妥及簽署申請表格。只接納親筆簽名（不得以個人印章代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須附一張獨立開出支票或一張獨立 開出銀行本票。支票或銀行本票必須符合以下所有規定，否則有關的認購申請不獲接納： le
支票必須：			銀行本票必須：
• 為港元； • 不得為期票； • 註明抬頭人為「招商永隆受託代管有限公司－康龍化成公開發售」； • 劃線註明「只准入抬頭人賬戶」； am
• 從 閣下在香港的港元銀行賬戶中開 出；及 • 顯示 閣下的賬戶名稱，而該賬戶名稱 必須已預印在支票上，或由有關銀行授 權的人士在支票背書。賬戶名稱必須 與 閣下姓名╱名稱相同。如屬聯名申 請，賬戶名稱必須與排名首位申請人的 姓名╱名稱相同。 S			• 須由香港持牌銀行開出，並由有關銀 行授權的人士在銀行本票背面簽署核 證 閣下姓名╱名稱。銀行本票所示 姓名╱名稱須與 閣下姓名╱名稱相 同。如屬聯名申請，銀行本票背面所示 姓名╱名稱必須與排名首位申請人的姓 名╱名稱相同。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入下列任何一家分 行特設的收集箱： 招商永隆銀行有限公司 分行名稱 地址 香港島 總行 德輔道中45號 北角分行 英皇道361號 中區分行 德輔道中189號 九龍 旺角分行 彌敦道636號招商永隆銀行中心地庫 尖沙咀分行 加拿分道4號 5. 閣下可於下列時間遞交申請表格： 2019年11月14日（星期四）－上午九時正至下午五時正 2019年11月15日（星期五）－上午九時正至下午五時正 2019年11月16日（星期六）－上午九時正至下午一時正 2019年11月18日（星期一）－上午九時正至下午五時正 2019年11月19日（星期二）－上午九時正至下午五時正 2019年11月20日（星期三）－上午九時正至中午十二時正 6. 截止遞交申請的時間為2019年11月20日（星期三）中午十二時正。本公司將於當日上午十一時四十 五分至中午十二時正期間登記認購申請，唯一會影響此時間的變化因素為當日的天氣情況（詳見招 股說明書「如何申請香港發售股份」一節「10. 惡劣天氣對開始辦理申請登記的影響」）。 香港發售股份申請將會自2019年11月14日（星期四）起直至2019年11月20日（星期三）止。申請款 項（包括經紀佣金、證監會交易徵費及聯交所交易費）將由收款銀行於截止辦理申請登記後代表本 公司持有，且退款金額（如有）將於2019年11月27日（星期三）或之前不計利息退還予申請人。投資 者務請注意，預期股份將於2019年11月28日（星期四）於聯交所開始買賣。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [117 x 34] intentionally omitted <==

• Pharmaron Beijing Co., Ltd.[*]

• 康龍化成（北京）新藥技術股份有限公司

• (A joint stock company incorporated in the People’s Republic of China with limited liability) GLOBAL OFFERING

• Conditions of your application • confirm that you are aware of the restrictions on the Global A. Who can apply Offering in the Prospectus; 1. You and any person(s) for whose benefit you are applying • agree that none of the Company, the Joint Global must be 18 years of age or older and must have a Hong Coordinators, the Joint Sponsors, the Joint Bookrunners, Kong address. the Joint Lead Managers, the Underwriters, their respective

• 1. If you are a firm, the application must be in the individual directors, officers, employees, partners, agents and advisers members’ names. (the “Relevant Persons”) and the White Form eIPO
• 1. The number of joint applicants may not exceed four. Service Provider is or will be liable for any information and 4. If you are a body corporate, the application must be representations not in the Prospectus (and any supplement to signed by a duly authorised officer, who must state his it); representative capacity, and stamped with your corporation’s • undertake and confirm that you or the person(s) for whose chop. benefit you have made the application have not applied for
• 1. You must be outside the United States, not be a United or taken up, or indicated an interest for, and will not apply

• States Person (within the meaning of Regulation S under the for or take up, or indicate an interest for, any Offer Shares

• U.S. Securities Act) or a person described in paragraph (h) under the International Offering nor participated in the

• (3) of Rule 902 of Regulation S under the U.S. Securities International Offering;

• Act and not be a legal or natural person of the PRC. • agree to disclose to the Company, the H Share Registrar,

• 1. Unless permitted by the Listing Rules or any relevant receiving bank and the Relevant Persons any personal data

• waivers that have been granted by the Stock Exchange, you which they may require about you and the person(s) for

• cannot apply for any Hong Kong Offer Shares if you are: • an existing beneficial owner of shares in the Company whose benefit you have made the application; • if the laws of any place outside Hong Kong apply to your

• and/or any of its subsidiaries;

• • a Director or chief executive officer of the Company application, agree and warrant that you have complied with all such laws and none of the Company nor the Relevant

• and/or any of its subsidiaries;

• • a close associate of any of the above; Persons will breach any law outside Hong Kong as a result • a core connected person of the Company or will of the acceptance of your offer to purchase, or any action become a core connected person of the Company arising from your rights and obligations under the terms and immediately upon completion of the Global Offering; conditions contained in the Prospectus and this Application or Form;

• • have been allocated or have applied for or indicated • agree that once your application has been accepted, you may an interest in any Offer Shares under the International not rescind it because of an innocent misrepresentation; Offering. • agree that your application will be governed by the laws of Hong Kong;

• B. If you are a nominee • represent , warrant and undertake that (i) you understand You, as a nominee, may make more than one application for the that the Hong Kong Offer Shares have not been and will not

• Hong Kong Offer Shares by: (i) giving electronic instructions to be registered under the U.S. Securities Act; and (ii) you and

• HKSCC via Central Clearing and Settlement System (“CCASS”) any person for whose benefit you are applying for the Hong

• (if you are a CCASS Participant); or (ii) using a WHITE or Kong Offer Shares are outside the United States (as defined

• YELLOW Application Form, and lodge more than one application in Regulation S) or are a person described in paragraph (h)

• in your own name on behalf of different beneficial owners. (3) of Rule 902 of Regulation S;

• C. Effect of completing and submitting this Application • warrant that the information you have provided is true and Form accurate;

• By completing and submitting this Application Form, you (and • agree to accept the Hong Kong Offer Shares applied for, or if you are joint applicants, each of you jointly and severally) for any lesser number allocated to you under the application; yourself or as an agent or a nominee on behalf of each person for • authorise the Company to place your name(s) on the whom you act: Company’s register of members as the holder(s) of any • undertake to execute all relevant documents and instruct Hong Kong Offer Shares allocated to you, and the Company and authorise the Company and/or the Joint Global and/or its agents to send any share certificate(s) and/or Coordinators (or their agents or nominees), as agents of the any refund cheque(s) to you or the first-named applicant Company, to execute any documents for you and to do on for joint application by ordinary post at your own risk your behalf all things necessary to register any Hong Kong to the address stated on the application, unless you have Offer Shares allocated to you in your name as required by fulfilled the criteria set out in “Personal Collection” in the the Articles of Association; “How to Apply for Hong Kong Offer Shares” section in the

• • agree to comply with the Companies Ordinance (Cap. 622), Prospectus to collect the share certificate(s) and/or refund

• the Companies (Winding Up and Miscellaneous Provisions) cheque(s) in person;

• You and any person(s) for whose benefit you are applying • agree that none of the Company, the Joint Global must be 18 years of age or older and must have a Hong Coordinators, the Joint Sponsors, the Joint Bookrunners, Kong address. the Joint Lead Managers, the Underwriters, their respective

• If you are a firm, the application must be in the individual directors, officers, employees, partners, agents and advisers members’ names. (the “Relevant Persons”) and the White Form eIPO

• The number of joint applicants may not exceed four. Service Provider is or will be liable for any information and 4. If you are a body corporate, the application must be representations not in the Prospectus (and any supplement to signed by a duly authorised officer, who must state his it); representative capacity, and stamped with your corporation’s • undertake and confirm that you or the person(s) for whose chop. benefit you have made the application have not applied for

• You must be outside the United States, not be a United or taken up, or indicated an interest for, and will not apply

States Person (within the meaning of Regulation S under the for or take up, or indicate an interest for, any Offer Shares

U.S. Securities Act) or a person described in paragraph (h) under the International Offering nor participated in the

(3) of Rule 902 of Regulation S under the U.S. Securities International Offering;

Act and not be a legal or natural person of the PRC. • agree to disclose to the Company, the H Share Registrar,

1. Unless permitted by the Listing Rules or any relevant receiving bank and the Relevant Persons any personal data

waivers that have been granted by the Stock Exchange, you which they may require about you and the person(s) for

cannot apply for any Hong Kong Offer Shares if you are: • an existing beneficial owner of shares in the Company whose benefit you have made the application; • if the laws of any place outside Hong Kong apply to your

and/or any of its subsidiaries;

• a Director or chief executive officer of the Company application, agree and warrant that you have complied with all such laws and none of the Company nor the Relevant

and/or any of its subsidiaries;

• a close associate of any of the above; Persons will breach any law outside Hong Kong as a result • a core connected person of the Company or will of the acceptance of your offer to purchase, or any action become a core connected person of the Company arising from your rights and obligations under the terms and immediately upon completion of the Global Offering; conditions contained in the Prospectus and this Application or Form;

• have been allocated or have applied for or indicated • agree that once your application has been accepted, you may an interest in any Offer Shares under the International not rescind it because of an innocent misrepresentation; Offering. • agree that your application will be governed by the laws of Hong Kong;

B. If you are a nominee • represent , warrant and undertake that (i) you understand You, as a nominee, may make more than one application for the that the Hong Kong Offer Shares have not been and will not Hong Kong Offer Shares by: (i) giving electronic instructions to be registered under the U.S. Securities Act; and (ii) you and HKSCC via Central Clearing and Settlement System (“CCASS”) any person for whose benefit you are applying for the Hong (if you are a CCASS Participant); or (ii) using a WHITE or Kong Offer Shares are outside the United States (as defined YELLOW Application Form, and lodge more than one application in Regulation S) or are a person described in paragraph (h) in your own name on behalf of different beneficial owners. (3) of Rule 902 of Regulation S;

• agree to comply with the Companies Ordinance (Cap. 622), the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) and the Articles of Association;

• understand that the Company and the Joint Global Coordinators will rely on your declarations and representations in deciding whether or not to make any allotment of any of the Hong Kong Offer Shares to you and that you may be prosecuted for making a false declaration;

• • declare and represent that this is the only application made and the only application intended by you to be made to benefit you or the person for whose benefit you are applying;

• confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;

• confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

• For identification purposes only

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

• (if the application is made for your own benefit) warrant that no other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC or to the White Form eIPO Service Provider by you or by any one as your agent or by any other person; and

If you apply for less than 1,000,000 Hong Kong Offer Shares, your refund cheque(s) and/or H Share certificate(s) will be sent to the address on the relevant Application Form on or before Wednesday, November 27, 2019, by ordinary post and at your own risk.

Refund of your money

• (if you are making the application as an agent for the benefit of another person) warrant that (i) no other application has If you do not receive any Hong Kong Offer Shares or if your been or will be made by you as agent for or for the benefit of application is accepted only in part, the Company will refund to that person or by that person or by any other person as agent you your application monies (including the related 1% brokerage, for that person on a WHITE or YELLOW Application Form 0.0027% SFC transaction levy and 0.005% Stock Exchange or by giving electronic application instructions to HKSCC trading fee) without interest. If the Offer Price is less than the and (ii) you have due authority to sign the Application Form maximum Offer Price, the Company will refund to you the surplus or give electronic application instructions on behalf of that application monies (including the related 1% brokerage, 0.0027% other person as their agent. SFC transaction levy and 0.005% Stock Exchange trading fee) without interest. D. Power of attorney If your application is made through an authorised attorney, the The refund procedures are stated in the “14. Dispatch/Collection of Company and the Joint Global Coordinators may accept or reject H Share Certificates and Refund Monies” in the “How to Apply for your application at their discretion, and on any conditions they Hong Kong Offer Shares” section of the Prospectus. think fit, including evidence of the attorney’s authority. Application by HKSCC Nominees Limited (“HKSCC Determination of Offer Price and Allocation of Hong Kong Nominees”) Offer Shares Where this Application Form is signed by HKSCC Nominees The Offer Price is expected to be fixed on or around Thursday, on behalf of persons who have given electronic application November 21, 2019. Applicants are required to pay the maximum instructions to apply for the Hong Kong Offer Shares, the Offer Price of HK$39.50 for each Hong Kong Offer Share together provisions of this Application Form which are inconsistent with with 1% brokerage, 0.0027% SFC transaction levy and 0.005% those set out in the Prospectus shall not apply and provisions in Stock Exchange trading fee. If the Offer Price is not agreed among the Prospectus shall prevail. the Company and the Joint Global Coordinators (for themselves and Without limiting the generality of this paragraph, the following on behalf of the Underwriters) on or before Tuesday, November 26, sections of this Application Form are inapplicable where this form 2019, the Global Offering will not proceed. is signed by HKSCC Nominees: Applications for Hong Kong Offer Shares will not be processed • “Applicants’ declaration” on the first page; and no allotment of any Hong Kong Offer Shares will be made • “Warning” on the first page; until the application lists close. • “If you are a nominee”; • All representations and warranties under the “Effect of The Company expects to announce the fixed offer price, the completing and submitting this Application Form” section, indication of the level of interest in the International Offering, except the first one regarding registration of Hong Kong the level of applications under the Hong Kong Public Offering Offer Shares in the applicant’s name and the signing of and the basis of allocation of the Hong Kong Offer Shares on documents to enable the applicant to be registered as the Wednesday, November 27, 2019 on the website of the Stock holder of the Hong Kong Offer Shares; Exchange at www.hkexnews.hk and the Company’s website at • “If your application for Hong Kong Offer Shares is www.pharmaron.com . Results of allocations and the Hong Kong successful (in whole or in part)”; and Identity Card/passport/Hong Kong business registration numbers • “Refund of your money”. of successful applicants (where applicable) will be available on the above websites. The following sections in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus are inapplicable where If your application for Hong Kong Offer Shares is successful this form is signed by HKSCC Nominees: (in whole or in part) • “How many applications you can make”; and If you apply for 1,000,000 or more Hong Kong Offer Shares, you • “Circumstances in which you will not be allotted Offer may collect refund cheque(s) and/or share certificate(s) in person Shares”. from Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Effect of the Information You Give to Computershare Hong Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. on Kong Investor Services Limited Wednesday, November 27, 2019 or such other date notified by us Computershare Hong Kong Investor Services Limited and its in the newspapers. related bodies corporate, directors, officers, employees and agents (“ Representatives ”) expressly disclaim and exclude to the If you are an individual who is eligible for personal collection, maximum extent permitted by law any liability for any loss or you must not authorise any other person to collect for you. If you damage suffered or incurred by the applicant or any other person are a corporate applicant which is eligible for personal collection, or entity however caused relating in any way to, or connected your authorised representative must bear a letter or authorisation with, any information provided by or on behalf of the applicant from your corporation stamped with your corporation’s chop. Both on or in connection with this document or any services provided individuals and authorised representatives must produce, at the time hereunder, or any other written or oral communication provided of collection, evidence of identity acceptable to Computershare Hong by or on behalf of the applicant in connection with this document Kong Investor Services Limited. or any services provided hereunder. This includes, without limitation, any errors or omissions in such information however If you do not collect your refund cheque(s) and/or H Share caused, or the Representatives or any other person or entity certificate(s) personally within the time period specified for placing any reliance on such information or any documentation, collection, they will be dispatched promptly to the address as image, recording or reproduction of such information, or its specified on this Application Form by ordinary post at your own accuracy, completeness, currency or reliability.

If you do not collect your refund cheque(s) and/or H Share certificate(s) personally within the time period specified for collection, they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

==> picture [117 x 34] intentionally omitted <==

• Pharmaron Beijing Co., Ltd.[*]

• 康龍化成（北京）新藥技術股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 全球發售

• 申請條件 • 確認 閣下知悉招股說明書內有關全球發售的限制； 甲、可提出申請的人士 • 同意 本公司、聯席全球協調人、聯席保薦人、聯席賬簿 1. 閣下及 閣下為其利益提出申請的人士必須年滿18歲並 管理人、聯席牽頭經辦人、承銷商，彼等各自的董事、 有香港地址。 高級職員、僱員、合夥人、代理及顧問（「有關人士」）

• 1. 如 閣下為商號，申請須以個別成員名義提出。 及 白表eIPO 服務供應商現時及日後均毋須對並非載於 3. 聯名申請人不得超過四名。 招股說明書（及其任何補充文件）的任何資料及陳述負 4. 如 閣下為法人團體，申請須經獲正式授權人員簽署， 責； 並註明其所屬代表身份及蓋上公司印鑑。 • 承諾 及 確認 閣下或 閣下為其利益提出申請的人士並
• 1. 閣下必須身處美國境外，並非美籍人士（定義見美國證 無申請或接納或表示有意認購（亦不會申請或接納或表 券法S規例）或屬美國證券法S規例第902條第(h)(3)段所 示有意認購）國際發售的任何發售股份，也沒有參與國 述的人士，亦非中國法人或自然人。 際發售；
• 1. 除上市規則或聯交所已授予的任何相關豁免批准外，下 • 同意 在本公司、H 股證券登記處、收款銀行及有關人 列人士概不得申請認購任何香港發售股份： 士提出要求時，向彼等披露其所要求提供有關 閣下 • 本公司及╱或其任何附屬公司股份的現有實益擁 及 閣下為其利益提出申請的人士的個人資料； 有人； • 若香港境外任何地方的法例適用於 閣下的申請，則 同

• • 本公司及╱或其任何附屬公司的董事或行政總裁； 意 及 保證 閣下已遵守所有有關法例，且本公司及有關 • 上述任何人士的緊密聯繫人； 人士概不會因接納 閣下的購買要約，或 閣下在招股 • 本公司核心關連人士或緊隨全球發售完成後成為本 說明書及本申請表格所載的條款及條件項下的權利及責 公司核心關連人士的人士；或 任所引致的任何行動，而違反香港境外的任何法例；

• • 已獲分配或已申請或表示有意申請國際發售的任何 • 同意 閣下的申請一經接納，即不得因無意的失實陳述 發售股份。 而撤銷； • 同意 閣下的申請受香港法例規管；

• 乙、如 閣下為代名人 • 聲明 、 保證 及 承諾 ：(i) 閣下明白香港發售股份不曾亦 閣下作為代名人可提交超過一份香港發售股份申請，方法 不會根據美國證券法登記；及(ii) 閣下及 閣下為其 是：(i)透過中央結算及交收系統（「中央結算系統」）向香港結 利益申請香港發售股份的人士均身處美國境外（定義見 算發出電子認購指示（如 閣下為中央結算系統參與者）；或 S規例），或屬S規例第902條第(h)(3)段所述的人士； (ii)使用 白色 或 黃色 申請表格，以自身名義代表不同的實益擁 • 保證 閣下提供的資料真實及準確； 有人提交超過一份申請。 • 同意 接納所申請數目或根據申請分配予 閣下但數目較 少的香港發售股份；

• 丙、填交本申請表格的效用 • 授權 本公司將 閣下的姓名╱名稱列入本公司股東名 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申請 冊，作為 閣下獲分配的任何香港發售股份的持有人， 人，即各人共同及個別）代表 閣下本身，或作為 閣下代 並授權本公司及╱或其代理以普通郵遞方式按申請所 其行事的每位人士的代理或代名人： 示地址向 閣下或聯名申請的首名申請人發送任何股票 • 承諾 簽立所有相關文件，並指示及授權本公司及╱或 及╱或退款支票，郵誤風險由 閣下承擔，除非 閣 聯席全球協調人（或彼等的代理或代名人）（作為本公司 下已符合招股說明書「如何申請香港發售股份」一節「親 代理），為按照組織章程細則的規定將 閣下獲分配的 身領取」所載條件親身領取股票及╱或退款支票； 任何香港發售股份以 閣下名義登記而代表 閣下簽立 • 明白 本公司及聯席全球協調人將依據 閣下的聲明及陳 任何文件及代 閣下進行一切必要事宜； 述而決定是否向 閣下分配任何香港發售股份， 閣下

• 授權 本公司將 閣下的姓名╱名稱列入本公司股東名 冊，作為 閣下獲分配的任何香港發售股份的持有人， 並授權本公司及╱或其代理以普通郵遞方式按申請所 示地址向 閣下或聯名申請的首名申請人發送任何股票 及╱或退款支票，郵誤風險由 閣下承擔，除非 閣 下已符合招股說明書「如何申請香港發售股份」一節「親 身領取」所載條件親身領取股票及╱或退款支票；

• • 明白 本公司及聯席全球協調人將依據 閣下的聲明及陳 述而決定是否向 閣下分配任何香港發售股份， 閣下 如作出虛假聲明，可能會被檢控；

• 同意 遵守第622 章公司條例、第32 章公司（清盤及雜項 條文）條例及組織章程細則；

• 聲明 及 陳述 此乃 閣下為本身或為其利益提出申請的人 士所提出及擬提出的唯一申請；

• 確認 閣下已細閱招股說明書及本申請表格所載的條款 及條件以及申請程序，並同意受其約束；

• 確認 閣下已接獲及細閱招股說明書，提出申請時也僅 依據招股說明書載列的資料及陳述，而除招股說明書任 何補充文件外，不會依賴任何其他資料或陳述；

• 僅供識別。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• （如本申請為 閣下本身的利益提出） 保證 閣下或作 為 閣下代理的任何人士或任何其他人士不曾亦不會 為 閣下的利益以 白色 或 黃色 申請表格或向香港結算或 向 白表eIPO 服務供應商發出電子認購指示而提出其他 申請；及

如 閣下申請認購1,000,000股以下香港發售股份， 閣下的 退款支票及╱或H股股票將於2019 年11 月27 日（星期三）或 以前以普通郵遞方式寄往相關申請表格所示地址，郵誤風險 由 閣下承擔。

退回款項

• （如 閣下作為代理為另一人士的利益提出申請） 保證 若 閣下未獲分配任何香港發售股份或申請僅部分獲接納， (i) 閣下（作為代理或為該人士利益）或該人士或任何 本公司將不計利息退回 閣下的申請股款（包括相關的1%經 其他作為該人士代理的人士不曾亦不會以 白色 或 黃色 申 紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易費）。 請表格或向香港結算發出電子認購指示而提出其他申 如發售價低於最高發售價，本公司將不計利息退回多收申請 請；及(ii) 閣下獲正式授權作為該人士的代理代為簽 股款（包括相關的1%經紀佣金、0.0027%證監會交易徵費及 署本申請表格或發出電子認購指示。 0.005%聯交所交易費）。 丁、授權書 有關退款程序載於招股說明書「如何申請香港發售股份」一節 如 閣下透過授權代理人提出申請，本公司及聯席全球協調 「14. 發送╱領取H股股票及退款」。14. 發送╱領取H股股票及退款」。發送╱領取H股股票及退款」。H股股票及退款」。股股票及退款」。 人可按其認為合適的條件（包括出示獲授權證明）酌情接納或 香港中央結算（代理人）有限公司（「香港結算代理人」）提出 拒絕 閣下的申請。 的申請 如本申請表格由香港結算代理人代表發出電子認購指示申請 釐定發售價及香港發售股份的分配 香港發售股份的人士簽署，本申請表格與招股說明書不符的 預期發售價於2019 年11 月21 日（星期四）或前後釐定。申請 條文將不適用，且以招股說明書所述者為準。 人須繳付每股香港發售股份39.50 港元的最高發售價，另加 1%經紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易 在不限制此段一般應用的前提下，本申請表格的以下部分在 費。倘若本公司與聯席全球協調人（為其本身及代表承銷商） 香港結算代理人作簽署人的情況下並不適用： 並無於2019 年11 月26 日（星期二）或之前協定發售價，全球 • 第一頁的「申請人聲明」； 發售將不會進行。 • 第一頁的「警告」； • 「如 閣下為代名人」； • 「填交本申請表格的效用」一節項下的所有陳述及保證， 截止登記認購申請前，概不處理香港發售股份的申請或配發 惟首項有關以申請人名義登記香港發售股份及簽署使申 任何香港發售股份。 請人登記成為香港發售股份持有人的文件除外； • 「如 閣下成功申請認購香港發售股份（全部或部分）」； 本公司預期於2019年11月27日（星期三）在聯交所網站( www. 及 hkexnews.hk )及本公司網站( www.pharmaron.com )公佈協定 • 「退回款項」。 發售價、國際發售踴躍程度、香港公開發售認購申請數目及 香港發售股份分配基準。分配結果以及獲接納申請人的香港 招股說明書「如何申請香港發售股份」一節的以下部分在香港 身份證╱護照╱香港商業登記號碼（如適用）亦同於上述網 結算代理人作簽署人的情況下並不適用： 站公佈。 • 「閣下可提交的申請數目」；及 • 「閣下不獲配發發售股份的情況」。 如 閣下成功申請認購香港發售股份（全部或部分） 閣下提供給香港中央證券登記有限公司的資料的有關影響 如 閣下申請認購1,000,000股或以上香港發售股份， 閣下 香港中央證券登記有限公司和其有關聯的法人團體、董事、 可於2019 年11 月27 日（星期三）或吾等於報章通知的其他日 高級人員、僱員及代理人（「 代表 」）在法律所容許的最大限 期上午九時正至下午一時正自香港中央證券登記有限公司 度內明確卸棄及免除在任何方面與申請人或代表申請人在此 （地址為香港灣仔皇后大道東183號合和中心17樓1712-1716 文件提供的或與此文件或在此文件下提供的任何服務相關的 室）領取退款支票及╱或股票。 任何資料，或任何申請人或代表申請人提供與此文件或在此 文件下提供的任何服務相關的任何其他書面或口頭通訊，有 如 閣下為個人申請人並合資格親身領取， 閣下不得授權 關或相關由申請人或任何其他人士或實體所遭受或招致不論 任何其他人士代領。如 閣下為公司申請人並合資格派人領 如何造成的任何損失或損害的任何法律責任。此包括，但不 取， 閣下的授權代表須攜同蓋上公司印鑑的授權書領取。 限於，該等資料中不論如何造成的任何錯誤或遺漏，或代表 個人申請人及授權代表領取股票時均須出示香港中央證券登 或任何其他人士或實體對該等資料或任何該等資料的文件記 記有限公司接納的身份證明文件。 錄、影像、記錄或複製品作出的任何依據，或其準確性、完 整性、合時性或可靠性。

有關退款程序載於招股說明書「如何申請香港發售股份」一節 「14. 發送╱領取H股股票及退款」。14. 發送╱領取H股股票及退款」。發送╱領取H股股票及退款」。H股股票及退款」。股股票及退款」。

如 閣下並無在指定領取時間內親身領取退款支票及╱或 H股股票，有關支票及╱股票將會立刻以普通郵遞方式寄往 本申請表格所示地址，郵誤風險由 閣下承擔。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

Personal Data

3. Transfer of personal data Personal data held by the Company and its H Share Registrar relating to the securities holders will be kept confidential but the Company and its H Share Registrar may, to the extent necessary for achieving any of the above purposes, disclose, obtain or transfer (whether within or outside Hong Kong) the personal data to, from or with any of the following:

Personal Information Collection Statement

This Personal Information Collection Statement informs the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company and its H Share Registrar in relation to personal data and the Personal Data (Privacy) Ordinance (Cap. 486) (the “Ordinance”).

• the Company’s appointed agents such as financial

1. Reasons for the collection of your personal data the Company’s appointed agents such as financial It is necessary for applicants and registered holders of advisers, receiving bankers and overseas principal securities to supply correct personal data to the Company share registrar; or its agents and the H Share Registrar when applying • where applicants for securities request a deposit into for securities or transferring securities into or out of CCASS, HKSCC or HKSCC Nominees, who will their names or in procuring the services of the H Share use the personal data for the purposes of operating Registrar. CCASS; • any agents, contractors or third-party service providers Failure to supply the requested data may result in your who offer administrative, telecommunications, application for securities being rejected, or in delay or computer, payment or other services to the Company or the inability of the Company or its H Share Registrar to the H Share Registrar in connection with their respective effect transfers or otherwise render their services. It may business operation; also prevent or delay registration or transfers of the Hong • the Stock Exchange, the SFC and any other statutory Kong Offer Shares which you have successfully applied regulatory or governmental bodies or otherwise as for and/or the dispatch of share certificate(s) and/or refund required by laws, rules or regulations; and cheque(s) to which you are entitled. • any persons or institutions with which the securities’ holders have or propose to have dealings, such as It is important that securities holders inform the Company their bankers, solicitors, accountants or stockbrokers and the H Share Registrar immediately inaccuracies in the etc. personal data supplied. 4. Retention of personal data 2. Purposes The Company and its H Share Registrar will keep the The personal data of the securities holders may be used, personal data of the applicants and holders of securities held, processed, and/or stored (by whatever means) for the for as long as necessary to fulfil the purposes for which following purposes: the personal data were collected. Personal data which • processing your application and refund cheque, where is no longer required will be destroyed or dealt with in applicable, verification of compliance with the terms accordance with the Ordinance. and application procedures set out in this Application Form and the Prospectus and announcing results of 5. Access to and correction of personal data allocation of the Hong Kong Offer Shares; Securities holders have the right to ascertain whether the • compliance with applicable laws and regulations in Company or the H Share Registrar hold their personal Hong Kong and elsewhere; data, to obtain a copy of that data, and to correct any data • registering new issues or transfers into or out of that is inaccurate. The Company and the H Share Registrar the names of securities’ holders including, where have the right to charge a reasonable fee for the processing applicable, HKSCC Nominees; of such requests. • maintaining or updating the register of securities’ holders of the Company; All requests for access to data or correction of data should • verifying securities holders’ identities; • establishing benefit entitlements of securities’ holders be addressed to us, at our registered address disclosed in the “Corporate Information” section of the Prospectus of the Company, such as dividends, rights issues, or as notified from time to time, for the attention of the bonus issues, etc.; • distributing communications from the Company and company secretary, or our H Share Registrar for the attention of the privacy compliance officer.

• verifying securities holders’ identities;

• distributing communications from the Company and its subsidiaries;

• compiling statistical information and securities’ holder profiles;

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

• disclosing relevant information to facilitate claims on entitlements; and

• any other incidental or associated purposes relating to the above and/or to enable the Company and the H Share Registrar to discharge their obligations to securities’ holders and/or regulators and/or any other purposes to which the securities’ holders may from time to time agree.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

個人資料

個人資料收集聲明

3. 轉交個人資料

此項個人資料收集聲明是向香港發售股份的申請人 和持有人說明有關本公司及其H股證券登記處有關H股證券登記處有關股證券登記處有關 個人資料和第 486 章《個人資料（私隱）條例》（「條 例」）方面的政策和慣例。

和持有人說明有關本公司及其H股證券登記處有關H股證券登記處有關股證券登記處有關 本公司及其H股證券登記處所持有關證券持有人的 個人資料和第 486 章《個人資料（私隱）條例》（「條 個人資料將會保密，但本公司及其H股證券登記處 例」）方面的政策和慣例。 可以在為達到上述任何目的之必要情況下，向下列 任何人士披露，獲取或轉交（無論在香港境內或境 1. 收集 閣下個人資料的原因 外）有關個人資料： 證券申請人及登記持有人以本身名義申請證券或轉 • 本公司委任的代理人，例如財務顧問、收款銀 讓或受讓證券時或尋求H股證券登記處的服務時， 行和主要海外股份過戶登記分處； 必須向本公司或其代理人及H股證券登記處提供準 • （如證券申請人要求將證券存於中央結算系統） 確個人資料。 香港結算或香港結算代理人，彼等將會就中央 結算系統的運作使用有關個人資料； 未能提供所要求的資料可能導致 閣下申請證券被 • 向本公司或H股證券登記處提供與其各自業務 拒或延遲，或本公司或其H股證券登記處無法落實 營運有關的行政、電訊、電腦、付款或其他服 轉讓或提供服務。此舉也可能妨礙或延遲登記或轉 務的任何代理人、承包商或第三方服務供應 讓 閣下成功申請的香港發售股份及╱或寄發 閣 商； 下應得的股票及╱或退款支票。 • 聯交所、證監會及任何其他法定監管機關或政 府部門或遵照其他法例、規則或法規；及 證券持有人所提供的個人資料如有任何錯誤，須立 • 證券持有人與其進行或擬進行交易的任何人士 即通知本公司及H股證券登記處。 或機構，例如彼等的銀行、律師、會計師或股 票經紀等。 2. 目的 證券持有人的個人資料可被採用及以任何方式持 4. 個人資料的保留 有、處理及╱或保存，以作下列用途： 本公司及其H股證券登記處將按收集個人資料所需 • 處理 閣下的申請及退款支票（如適用）、核 的用途保留證券申請人及持有人的個人資料。無需 實是否符合本申請表格及招股說明書載列的條 保留的個人資料將會根據條例銷毀或處理。 款和申請程序以及公佈香港發售股份的分配結 果； 5. 查閱和更正個人資料 • 遵守香港及其他地區的適用法律及法規； 證券持有人有權確定本公司或H股證券登記處是否 • 以證券持有人（包括香港結算代理人（如適用）） 持有其個人資料，並有權索取有關該資料的副本並 的名義登記新發行證券或轉讓或受讓證券； 更正任何不準確資料。本公司和H股證券登記處有 • 存置或更新本公司證券持有人的名冊； 權就處理任何查閱資料的要求收取合理費用。 • 核實證券持有人的身份； • 確定本公司證券持有人的受益權利，例如股 所有查閱資料或更正資料的要求應按招股說明書 息、供股和紅股等； 「公司資料」一節所披露或不時通知的本公司註冊地 • 分發本公司及其附屬公司的通訊； 址送交公司秘書，或向本公司的H股證券登記處的H股證券登記處的股證券登記處的

• 所有查閱資料或更正資料的要求應按招股說明書

• 「公司資料」一節所披露或不時通知的本公司註冊地 址送交公司秘書，或向本公司的H股證券登記處的H股證券登記處的股證券登記處的 個人資料私隱事務主任提出。

• 編製統計數據和證券持有人資料；

• 披露有關資料以便就權益索償；及

• 與上述有關的任何其他附帶或相關目的及╱或 使本公司及H股證券登記處能履行對證券持有 人及╱或監管機構承擔的責任及╱或證券持有 人不時同意的任何其他目的。

• 閣下簽署申請表格或向香港結算發出電子認購指 示，即表示同意上述各項。